Back to MW MARSHALL WACE, LLP
NGEN2 quarters
Position history for MWMARSHALL WACE, LLP's holdings in NERVGEN PHARMA CORP
MARSHALL WACE, LLP holds 435,962 shares of NGEN (NERVGEN PHARMA CORP), worth $898,081 as of 2026-Q2. The position was increased (+117.6% shares). NGEN represents 0.0% of MARSHALL WACE, LLP's portfolio.
Current Value
$898,081
Current Shares
435,962
Total Value Change
+$142,726
Total Shares Change
+235,603
Quarter-by-Quarter History
Other major holders of NGEN: LMR Partners LLP, UBS Group AG, BANK OF AMERICA CORP /DE/, ROYAL BANK OF CANADA, JANE STREET GROUP, LLC